Gene Therapy Clinical Trials

Our site has years of experience with over 300 patients with Inherited Retinal Diseases (IRD) in our clinic. NEED TEXT

Clinical Trial Site Parameters

  • Experienced Retina Surgeons
  • Site Specific Research Coordinators
  • Ophthalmic Genetic Counselor
  • Specialized Lab Space
  • Microscope
  • What else?

Ascent Gene Therapy Clinical Trial

This clinical trial evaluates a gene therapy product, RGX-314, for patients with choroidal neovascularization (CNV), a form of wet age-related macular degeneration (AMD). The purpose of this study is to evaluate the safety and efficacy of a single RGX-314 subretinal injection in participants with AMD compared to repeated intravitreal (ITV) injections.

Ascent Study